2m 2m 2m 2m 2m 2m 2m
Fulgent Genetics (FLGT)
NASDAQ
$19.92+$0.02 (+0.12%)
Price as of Aug 21, 2026 7:30 PM EDT- $547.6MMarket Cap
- -8.59%1-Year Change
- Diagnostics & ResearchIndustry
Fulgent Genetics (FLGT)
$19.92+$0.02 (+0.12%)
FLGT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $19.90 | ||
Change | -$0.02 (-0.10%) | ||
Open | $20.01 | ||
High | $20.04 | ||
Low | $19.57 | ||
Previous Close | $19.92 | ||
Volume | 323,967 | ||
30-Day Average Volume | 302,233 | ||
1-Week Change | 7.22% | ||
1-Month Change | 0.10% | ||
1-Year Change | -8.59% | ||
3-Year Change | -40.61% | ||
5-Year Change | -78.10% | ||
Fundamentals | |||
Shares Outstanding | 27.5M | ||
Total Assets | $1.1B | ||
Market Cap | $547.6M | ||
Enterprise Value | $525.2M | ||
Period: QTR TTM FY | |||
Revenue | $85.4M | ||
Net Income | -$29.5M | ||
Free Cash Flow | -$27.6M | ||
EBIT | -$29.5M | ||
EBITDA | -$21.8M | ||
Net Working Capital | $383.0M | ||
EPS | N/A | ||
Enterprise Value/EBITDA | -24 | ||
Enterprise Value/Revenue | 6 | ||
P/B | 1 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | -20 | ||
Price/Operating Cash Flow | -23 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue